TrialInternational journal of hematology2023

Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial.

Noriko Fukuhara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.